 |
|
Home | CONMED Given “Neutral” Rating at Zacks (CNMD) |
 |
CONMED Given “Neutral” Rating at Zacks (CNMD)
|
 |
- August 29, 2012
-
CONMED (NASDAQ: CNMD)‘s stock had its “neutral” rating reaffirmed by Zacks in a research note issued on Wednesday. They currently have a $28.00 price target on the stock. A number of other firms have also recently commented on CNMD. Analysts at Needham & Company cut their price target on shares of CONMED from $35.00 to [...]This article (CONMED Given “Neutral” Rating at Zacks (CNMD)) was originally developed by and is property of American Banking News. Checkout American Banking News for up-to-date banking news and peer to peer lending news.
- Read more at:http://www.americanbankingnews.com/2012/08/29/conmed-given-neutral-rating-at-zacks-cnmd/
|
 |
|
 |
|
 |
